In This Section

Program

Please note that this meeting will take place as an in-person event in Bellevue and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference. Please see the registration page for details.

CME credit is available for in-person attendance for the designated sessions. On-demand presentations are not eligible for CME.

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise. Program in progress.

*-Short talk from proffered abstract

THURSDAY, NOVEMBER 14 

FRIDAY, NOVEMBER 15 

SATURDAY, NOVEMBER 16 

SUNDAY, NOVEMBER 17 

Thursday, November 14

WELCOME AND OPENING KEYNOTE

6-7 p.m.

  • Howard Y. Chang, Stanford University, Stanford, California
  • Joshua T. Mendell, University of Texas Southwestern Medical Center, Dallas, Texas
  • Anastasia Khvorova, University of Massachusetts Chan Medical School, Worcester, Massachusetts
  • Narry Kim, Seoul National University, Seoul, Korea 

Opening Keynote Address

7-8:30 p.m.

  • Davide Ruggero, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California
Friday, November 15

Continental Breakfast

7-8 a.m.

Plenary Session 1: Deregulation of RNA in cancer 

8-10 a.m.

  • Hani Goodarzi, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California
  • Robert Bradley, Fred Hutchinson Cancer Center, Seattle, Washington
  • Anna Nam, Weill Cornell Medicine, New York, New York

Plenary Session 2: Design of mRNA drugs 

10:30 a.m. – 12:30 p.m.

  • Kevin Weeks, UNC Chapel Hill, Durham, North Carolina
  • Giles Besin, Orbital Therapeutics, Cambridge, Massachusetts
  • Narry Kim, Seoul National University, Seoul, Korea

Lunch Break on own

12:30-2:30 p.m.

Plenary Session 3: Interaction between RNA drugs and the immune system 

2:30-4:30 p.m.

  • Sun Hur, Harvard Medical School, Boston, Massachusetts
  • Ling-Ling Chen, Shanghai Institute of Biochemistry and Cell Biology, Shanghai, China 
  • Serena Silver, Accent Therapeutics, Boston, Massachusetts

Poster Session A (with light refreshments)

4:30-7 p.m.

Saturday, November 16

Continental Breakfast

7-8 a.m.

Plenary Session 4: RNA delivery

8-10 a.m.

  • Aditya Raguram, Massachusetts Institute of Technology, Cambridge, Massachusetts
  • Additional speaker to be announced

Break

10-10:30 a.m.

Plenary Session 5:  RNAs as drivers and targets in cancer 

10:30 a.m. – 12:30 p.m.

  • Josh Mendell, University of Texas Southwestern Medical Center, Dallas, Texas
  • Nadya Dimitrova, Yale University, New Haven Connecticut
  • Howard Chang, Stanford University, Stanford, California

Lunch Break (lunch on your own) 

12:30-2:30 p.m.

Plenary Session 6:  Small RNA therapeutics 

2:30-4:30 p.m.

  • Anastasia Khvorova, University of Massachusetts Chan Medical School, Worcester, Massachusetts
  • Muthiah Manoharan, Alnylam Pharmaceuticals, Cambridge, Massachusetts
  • Andrew Denker, Flamingo, Philadelphia, Pennsylvania

Poster Session B (with light refreshments) 

4:30-7 p.m.

Sunday, November 17

Continental Breakfast

7-8 a.m.

Plenary Session 7: RNA for Cancer immunotherapy 

8-10 a.m.

  • Vinod Balachandran, Memorial Sloan Kettering Cancer Center, New York, New York
  • Crystal Mackall, Stanford University, Stanford, California 
  • Grace Chen, Yale University, New Haven, Connecticut 

Break

10-10:30 a.m.

Plenary Session 8: Emerging RNA Technologies

10:30 a.m.- 12:30 p.m.

  • Xiaojing Gao, Stanford University, Stanford, California
  • Matthew Disney, Scripps Research Institute, San Diego, California
  • Manjunath Ramarao, Atomic AI, Stanford, California

Closing Remarks

12:30-12:45 p.m.